<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170719035180N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-30</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effectiveness of emotional schema therapy and acceptance and commitment based on compassion on death anxiety and perfectionism and anger rumination in nurses.</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of emotional schema therapy and acceptance and commitment based on compassion  on death anxiety, anger rumination and perfectionism in nurses with obsessive personality traits working in the Corona ward.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Blinding description: The participants do not know which group they are in.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obsessive pathological personality trait.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: acceptance and commitment based compassion: first session: introducing members and creating a therapeutic relationship. Second session: recognition of three emotional systems (threat, driver and satisfaction). The third session: Defining and explaining the mind and that it is a problem (control). The fourth session: Knowing the three brains. Session 5: Introducing compassionate reasoning and techniques of compassionate attention and being present. Sixth session: Introduction of kind behaviors. Session Seven: Introduction to acceptance and tolerance of distress. Session eight: Explaining the fault and its strategies. Ninth session: Values and clients' awareness of the relationship of values. Session tenth: Explanation of values as a compass and the motivation to commit to moving towards them. Implementation of post-test and follow-up (one month after the post-test). Intervention 2: Intervention group: Emotion schema therapy. first session: introduction, explanation of group rules and group goals, second session: statement of general principles of emotional schema therapy, third session: normalization of emotion and dealing with guilt and shame schemas. The fourth session: giving credit to emotions and labeling emotions. The fifth session: cognitive reconstruction, explanation of the evidence review technique and dealing with the rumination schema. The sixth session: Compassion and self-compassionate description. The seventh session: Examining the problematic styles of discrediting, examining adaptive strategies to overcome discrediting. The eighth session: Teaching the lawyer's technique to deal with spontaneous thoughts and values. The ninth session: The technique of tolerating mixed feelings and explaining it, the tenth session: Consolidating new learnings. Through talking about obstacles and expressing feelings at the end of the group and performing the post-test and performing the follow-up phase one month after the post-test. Intervention 3: Control group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
after de-identification ,All data is shared.

When:
Access starts after the articles are published

To whom:
Psychology students and researchers

Conditions:
The results of the research are done without sending the statistics, if the statistics are requested, they will cooperate according to the needs of the researcher.

Where to obtain:
aidachoobsaz@outlook.com

How to obtain:
A request for documentation is made and the documentation is provided to the researcher within a week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Mosa Tabatabaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan University, Psychology and Educational sciences Faculty</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519956549</zip>
        <telephone>+98 23 3342 2765</telephone>
        <email>s.mosatabatabaee@semnan.ac.ir</email>
        <affiliation>Semnan University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Mosa Tabatabaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan University, Psychology and Educational sciences Faculty</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519956549</zip>
        <telephone>+98 23 3342 2765</telephone>
        <email>s.mosatabatabaee@semnan.ac.ir</email>
        <affiliation>Semnan University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Taking  informed consent of participants in the research
Having Three months of experience in the corona ward.</inclusion_criteria>
      <agemin>26 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Taking psychiatric drugs
receiving simultaneous psychotherapy
two session absence in group</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F60.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obsessive-compulsive personality disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: acceptance and commitment based compassion: first session: introducing members and creating a therapeutic relationship. Second session: recognition of three emotional systems (threat, driver and satisfaction). The third session: Defining and explaining the mind and that it is a problem (control). The fourth session: Knowing the three brains. Session 5: Introducing compassionate reasoning and techniques of compassionate attention and being present. Sixth session: Introduction of kind behaviors. Session Seven: Introduction to acceptance and tolerance of distress. Session eight: Explaining the fault and its strategies. Ninth session: Values and clients' awareness of the relationship of values. Session tenth: Explanation of values as a compass and the motivation to commit to moving towards them. Implementation of post-test and follow-up (one month after the post-test).</i_keyword>
      <i_keyword>Intervention group: Emotion schema therapy. first session: introduction, explanation of group rules and group goals, second session: statement of general principles of emotional schema therapy, third session: normalization of emotion and dealing with guilt and shame schemas. The fourth session: giving credit to emotions and labeling emotions. The fifth session: cognitive reconstruction, explanation of the evidence review technique and dealing with the rumination schema. The sixth session: Compassion and self-compassionate description. The seventh session: Examining the problematic styles of discrediting, examining adaptive strategies to overcome discrediting. The eighth session: Teaching the lawyer's technique to deal with spontaneous thoughts and values. The ninth session: The technique of tolerating mixed feelings and explaining it, the tenth session: Consolidating new learnings. Through talking about obstacles and expressing feelings at the end of the group and performing the post-test and performing the follow-up phase one month after the post-test.</i_keyword>
      <i_keyword>Control group:</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anger rumination (people who scored an average score in Sudolsky's Anger Rumination Questionnaire). Timepoint: before the start of intervention (pre-test), immediately  after the end of the intervention(post - test) and one month after that(follow up). Method of measurement: Sudolsky anger rumination scale.</prim_outcome>
      <prim_outcome>Death anxiety (people who got an average score in Templer's death anxiety questionnaire). Timepoint: before the start of intervention (pre-test), immediately  after the end of the intervention(post - test) and one month after that(follow up). Method of measurement: Templer Death Anxiety Scale.</prim_outcome>
      <prim_outcome>Perfectionism (people who got an average score in Tehran's Multidimensional perfectionism questionnaire). Timepoint: before the start of intervention (pre-test), immediately  after the end of the intervention(post - test) and one month after that(follow up). Method of measurement: Tehran multidimensional perfectionism scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-02-16</approval_date>
        <contact_name>ethics committee of shahrood azad University</contact_name>
        <contact_address>University Blvd., Shahrood, Semnan town shahrood Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
